Lilly's Competitive Clinical Research Grant
Lilly's Competitive Clinical Research Grant from Eli Lilly and Company funds independent clinical studies aligned with Lilly’s strategic research interests as defined in public RFPs.
Funder: Eli Lilly and Company
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: Funding and/or study drug support for independently managed investigator-initiated studies; award size and duration vary by RFP.
Summary: Supports external investigator-initiated clinical research in areas of strategic interest to Lilly, with topics and criteria set by public RFPs.
Description
Lilly's Competitive Clinical Research Grant, offered by Eli Lilly and Company, invites external researchers and institutions to submit proposals for investigator-initiated clinical studies aligned with Lilly's strategic research priorities. The program is structured around publicly posted Requests for Proposal (RFPs) that define specific research topics, timelines, and eligibility requirements. Proposals are evaluated by global committees of Lilly medical and scientific staff, and may also involve external reviewers. Approved projects are fully managed and sponsored by the grantee, ensuring independent study design and conduct while supporting Lilly’s research objectives.
